Free Trial

KalVista Pharmaceuticals (KALV) Insider Trading & Ownership

→ Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad)
Free KALV Stock Alerts
$12.41
+0.41 (+3.42%)
(As of 03:28 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.81 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$2.65 M
Get KALV Insider Trade Alerts

Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KALV Insider Buying and Selling by Quarter

Ad Small Cap Sniper
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely!
Learn how this American company is leading the lithium-ion revolution

KalVista Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/20/2024Benjamin L PalleikoCFOSell22,802$14.11$321,736.22  
2/20/2024Edward P FeenerInsiderSell28,288$14.07$398,012.16  
2/20/2024Thomas Andrew CrockettCEOSell24,888$14.11$351,169.68  
2/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy29,747$14.70$437,280.90  
2/6/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,474$14.74$65,946.76  
1/29/2024Venrock Healthcare Capital ParMajor ShareholderBuy80,600$14.22$1,146,132.00  
1/26/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,174$12.98$54,178.52  
1/24/2024Venrock Healthcare Capital ParMajor ShareholderBuy20,686$12.44$257,333.84  
1/22/2024Venrock Healthcare Capital ParMajor ShareholderBuy67,546$12.55$847,702.30  
1/18/2024Venrock Healthcare Capital ParMajor ShareholderBuy39,680$12.51$496,396.80  
1/16/2024Venrock Healthcare Capital ParMajor ShareholderBuy19,599$12.73$249,495.27  
1/11/2024Edward P FeenerInsiderSell22,679$13.03$295,507.37  
1/10/2024Venrock Healthcare Capital ParMajor ShareholderBuy47,700$12.67$604,359.00  
1/8/2024Edward P FeenerInsiderSell17,221$13.01$224,045.21  
1/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy69,184$12.44$860,648.96  
1/3/2024Venrock Healthcare Capital ParMajor ShareholderBuy17,605$12.20$214,781.00  
12/29/2023Venrock Healthcare Capital ParMajor ShareholderBuy6,013$12.49$75,102.37  
12/27/2023Thomas Andrew CrockettCEOSell30,000$12.02$360,600.00  
12/27/2023Venrock Healthcare Capital ParMajor ShareholderBuy41,514$11.97$496,922.58  
9/11/2023Albert ChaDirectorSell18,000$10.50$189,000.00  
8/18/2023Benjamin L PalleikoCFOSell13,067$10.73$140,208.91  
8/18/2023Paul K AudhyaInsiderSell8,020$10.73$86,054.60  
8/18/2023Thomas Andrew CrockettCEOSell14,876$10.73$159,619.48  
5/18/2023Benjamin L PalleikoCFOSell4,037$10.14$40,935.18  
5/18/2023Christopher YeaInsiderSell2,604$10.14$26,404.56  
5/18/2023Thomas Andrew CrockettCEOSell5,627$10.14$57,057.78  
(Data available from 1/1/2013 forward)

KALV Insider Trading Activity - Frequently Asked Questions

Who is on KalVista Pharmaceuticals's Insider Roster?

The list of insiders at KalVista Pharmaceuticals includes Albert Cha, Benjamin L Palleiko, Christopher Yea, Edward P Feener, Paul K Audhya, Thomas Andrew Crockett, and Venrock Healthcare Capital Par. Learn more on insiders at KALV.

What percentage of KalVista Pharmaceuticals stock is owned by insiders?

12.30% of KalVista Pharmaceuticals stock is owned by insiders. Learn more on KALV's insider holdings.

Which KalVista Pharmaceuticals insiders have been buying company stock?

The following insider purchased KALV shares in the last 24 months: Venrock Healthcare Capital Par ($5,806,280.30).

How much insider buying is happening at KalVista Pharmaceuticals?

Insiders have purchased a total of 448,522 KALV shares in the last 24 months for a total of $5,806,280.30 bought.

Which KalVista Pharmaceuticals insiders have been selling company stock?

The following insiders have sold KALV shares in the last 24 months: Albert Cha ($189,000.00), Benjamin L Palleiko ($544,755.63), Christopher Yea ($32,600.72), Edward P Feener ($917,564.74), Paul K Audhya ($112,190.52), and Thomas Andrew Crockett ($1,016,362.46).

How much insider selling is happening at KalVista Pharmaceuticals?

Insiders have sold a total of 232,618 KalVista Pharmaceuticals shares in the last 24 months for a total of $2,812,474.07 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:KALV) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way
Small Cap Sniper
Invest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a Century
Starpax
HUGE BUY ALERT: Move Fast, Musk...
Stansberry Research
Democrats Push to Replace Dollar With Digital Coin, Control Currency.
Monetary Gold
Trump’s “Tax Free” Retirement Strategy
Gold Safe Exchange
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals